Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy-Reference-Cited by-同舟云学术

Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy

Published:2018-02-16 Issue:5 Volume:121 Page:774-780
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Schlussel Markovic Emily¹,Buckstein Michael¹,Stone Nelson N.¹^ORCID,Stock Richard G.¹^ORCID

Affiliation:

1. Department of Radiation Oncology; Icahn School of Medicine at Mount Sinai; New York NY USA

Funder

Icahn School of Medicine at Mount Sinai

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14128/fullpdf

Reference24 articles.

1. Long-term oncological outcomes and toxicity in 597 men

2. Intensity-modulated radiation therapy from 70 Gy to 80 Gy in prostate cancer: six- year outcomes and predictors of late toxicity;Jolnerovski;Radiat Oncol,2017

3. Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation;Lee;Int J Radiat Oncol Biol Phys,2002

4. The evolution of brachytherapy for prostate cancer;Zaorsky;Nat Rev Urol,2017

5. Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy;Stock;Int J Radiat Oncol Biol Phys,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations;Prostate Cancer and Prostatic Diseases;2024-03-13

2. Racial Analysis of Clinical and Biochemical Outcomes in Patients With Prostate Cancer Treated With Low-Dose-Rate Brachytherapy;International Journal of Radiation Oncology*Biology*Physics;2023-05

3. Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity;Advances in Radiation Oncology;2023-05

4. A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life;Cancers;2023-02-20

5. Integrating external beam and prostate seed implant dosimetry for intermediate and high-risk prostate cancer using biologically effective dose: Impact of image registration technique;Brachytherapy;2022-11